ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
IBM announced plans to give the National Institutes of Health a database of more than 2.4 million chemical compounds. NIH will add this information to PubChem, a freely available database of chemical structures of small organic molecules and information on their biological activities. IBM pulled the chemical data from about 4.7 million patents and 11 million biomedical journal abstracts over the period of 1976 to 2000. According to the firm, the newly compiled data will help researchers more easily elucidate important relationships among chemical compounds and will aid drug discovery. IBM—which created the database in collaboration with AstraZeneca, Bristol-Myers Squibb, DuPont, and Pfizer—extracted the data using techniques such as automatic image analysis and enhanced optical recognition of chemical images and symbols.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X